127 related articles for article (PubMed ID: 7960980)
1. In vitro parameters and treatment outcome in head and neck cancers treated with surgery and/or radiation: cell characterization and correlations with local control and overall survival.
Girinsky T; Bernheim A; Lubin R; Tavakoli-Razavi T; Baker F; Janot F; Wibault P; Cosset JM; Duvillard P; Duverger A
Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):789-94. PubMed ID: 7960980
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: preliminary correlations with local control and overall survival.
Girinsky T; Lubin R; Pignon JP; Chavaudra N; Gazeau J; Dubray B; Cosset JM; Socie G; Fertil B
Int J Radiat Oncol Biol Phys; 1993 Jan; 25(1):3-7. PubMed ID: 8416879
[TBL] [Abstract][Full Text] [Related]
3. Relationship between tumour cell in vitro radiosensitivity and clinical outcome after curative radiotherapy for squamous cell carcinoma of the head and neck.
Stausbøl-Grøn B; Overgaard J
Radiother Oncol; 1999 Jan; 50(1):47-55. PubMed ID: 10225557
[TBL] [Abstract][Full Text] [Related]
4. Selective assessment of in vitro radiosensitivity of tumour cells and fibroblasts from single tumour biopsies using immunocytochemical identification of colonies in the soft agar clonogenic assay.
Stausbøl-Grøn B; Nielsen OS; Møller Bentzen S; Overgaard J
Radiother Oncol; 1995 Nov; 37(2):87-99. PubMed ID: 8747932
[TBL] [Abstract][Full Text] [Related]
5. Tumor radiosensitivity (SF2) is a prognostic factor for local control in head and neck cancers.
Björk-Eriksson T; West C; Karlsson E; Mercke C
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):13-9. PubMed ID: 10656366
[TBL] [Abstract][Full Text] [Related]
6. Impact of tumor control and presence of visible necrosis in head and neck cancer patients treated with radiotherapy or radiochemotherapy.
Kuhnt T; Mueller AC; Pelz T; Haensgen G; Bloching M; Koesling S; Schubert J; Dunst J
J Cancer Res Clin Oncol; 2005 Nov; 131(11):758-64. PubMed ID: 16088405
[TBL] [Abstract][Full Text] [Related]
7. In vitro radiosensitivity of tumour cells and fibroblasts derived from head and neck carcinomas: mutual relationship and correlation with clinical data.
Stausbøl-Grøn B; Bentzen SM; Jørgensen KE; Nielsen OS; Bundgaard T; Overgaard J
Br J Cancer; 1999 Mar; 79(7-8):1074-84. PubMed ID: 10098739
[TBL] [Abstract][Full Text] [Related]
8. Characterization and radiosensitivity of fibroblasts derived from squamous cell carcinomas of the head and neck, and the surrounding oral mucosa.
Stausbøl-Grøn B; Bentzen SM; Overgaard J
Acta Oncol; 1998; 37(7-8):697-700. PubMed ID: 10050990
[TBL] [Abstract][Full Text] [Related]
9. Radiosensitivity of human head and neck squamous cell carcinomas in primary culture and its potential as a predictive assay of tumor radiocurability.
Brock WA; Baker FL; Peters LJ
Int J Radiat Biol; 1989 Nov; 56(5):751-60. PubMed ID: 2573673
[TBL] [Abstract][Full Text] [Related]
10. Radiosensitivity of dermal and tumor fibroblasts derived from the same patient.
Honkanen J; Rantanen V; Kulmala J; Grénman R; Klemi P; Pekkola K
J Cancer Res Clin Oncol; 1998; 124(8):415-20. PubMed ID: 9750017
[TBL] [Abstract][Full Text] [Related]
11. Does pathologic node status affect local control in patients with carcinoma of the head and neck treated with radical surgery and postoperative radiotherapy?
Rudoltz MS; Benammar A; Mohiuddin M
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):503-8. PubMed ID: 7852112
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma.
van den Broek GB; Rasch CR; Pameijer FA; Peter E; van den Brekel MW; Tan IB; Schornagel JH; de Bois JA; Zijp LJ; Balm AJ
Cancer; 2004 Oct; 101(8):1809-17. PubMed ID: 15386309
[TBL] [Abstract][Full Text] [Related]
13. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U
Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111
[TBL] [Abstract][Full Text] [Related]
14. Determinants of complications and outcome in high-risk squamous cell head-and-neck cancer treated with perioperative high-dose rate brachytherapy (PHDRB).
Martínez-Monge R; Pagola Divassón M; Cambeiro M; Gaztañaga M; Moreno M; Arbea L; Montesdeoca N; Alcalde J
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e245-54. PubMed ID: 21620582
[TBL] [Abstract][Full Text] [Related]
15. Patterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinoma.
Murakami N; Matsumoto F; Yoshimoto S; Ito Y; Mori T; Ueno T; Tuchida K; Kashihara T; Kobayashi K; Harada K; Kitaguchi M; Sekii S; Umezawa R; Takahashi K; Inaba K; Igaki H; Itami J
BMC Cancer; 2016 Mar; 16():192. PubMed ID: 26951089
[TBL] [Abstract][Full Text] [Related]
16. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
[TBL] [Abstract][Full Text] [Related]
17. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis.
Begg AC; Haustermans K; Hart AA; Dische S; Saunders M; Zackrisson B; Gustaffson H; Coucke P; Paschoud N; Hoyer M; Overgaard J; Antognoni P; Richetti A; Bourhis J; Bartelink H; Horiot JC; Corvo R; Giaretti W; Awwad H; Shouman T; Jouffroy T; Maciorowski Z; Dobrowsky W; Struikmans H; Wilson GD
Radiother Oncol; 1999 Jan; 50(1):13-23. PubMed ID: 10225552
[TBL] [Abstract][Full Text] [Related]
18. Tumor volume predicts outcome for advanced head and neck cancer treated with targeted chemoradiotherapy.
Doweck I; Denys D; Robbins KT
Laryngoscope; 2002 Oct; 112(10):1742-9. PubMed ID: 12368607
[TBL] [Abstract][Full Text] [Related]
19. Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks.
Bourhis J; Dendale R; Hill C; Bosq J; Janot F; Attal P; Fortin A; Marandas P; Schwaab G; Wibault P; Malaise EP; Bobin S; Luboinski B; Eschwege F; Wilson G
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):471-6. PubMed ID: 8655369
[TBL] [Abstract][Full Text] [Related]
20. Postoperative radiotherapy in head and neck carcinoma with extracapsular lymph node extension and/or positive resection margins: a comparative study.
Huang DT; Johnson CR; Schmidt-Ullrich R; Grimes M
Int J Radiat Oncol Biol Phys; 1992; 23(4):737-42. PubMed ID: 1618666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
